Genetic Testing Services and Regulatory Concerns

The chapter delves into the accuracy and regulatory issues surrounding genetic testing services, focusing on the example of 23 and me. It discusses the FDA's intervention due to misleading claims, the importance of database size for accuracy, and critiques the inaccurate health information provided by the service. The conversation also explores the broader implications of individuals taking genetic test information into their own hands and the impact of direct-to-consumer health services on consumer decisions.